[
    [
        {
            "time": "2021-09-28",
            "original_text": "北向资金节前连续三日加仓累计净买入90亿，东方财富净买入超6亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "加仓",
                    "净买入",
                    "东方财富"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金节前连续三日加仓累计净买入90亿，东方财富净买入超6亿元",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "恒瑞医药（600276.SH）：盐酸伊立替康脂质体注射液、SHR-1701注射液获准开展临床试验",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "盐酸伊立替康脂质体注射液",
                    "SHR-1701注射液",
                    "临床试验"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药（600276.SH）：盐酸伊立替康脂质体注射液、SHR-1701注射液获准开展临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "恒瑞医药（600276.SH）：收到氟唑帕利胶囊、贝伐珠单抗注射液的药物临床试验批准通知书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "氟唑帕利胶囊",
                    "贝伐珠单抗注射液",
                    "临床试验"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药（600276.SH）：收到氟唑帕利胶囊、贝伐珠单抗注射液的药物临床试验批准通知书",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "A股融资融券日报：两融余额减少146.44亿元（9月27日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "减少"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少146.44亿元（9月27日）",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "北向资金动向盘点：食品饮料大涨，是最大受益者之一",
            "features": {
                "keywords": [
                    "北向资金",
                    "食品饮料",
                    "受益者"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "食品饮料"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金动向盘点：食品饮料大涨，是最大受益者之一",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "白酒股又香了！北向资金买入酿酒行业25亿元，“茅五”被大幅扫货",
            "features": {
                "keywords": [
                    "白酒股",
                    "北向资金",
                    "买入",
                    "茅五"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白酒股又香了！北向资金买入酿酒行业25亿元，“茅五”被大幅扫货",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "药明巨诺第2款CAR-T获批临床；康方生物AK120获FDA批准临试",
            "features": {
                "keywords": [
                    "药明巨诺",
                    "CAR-T",
                    "康方生物",
                    "FDA",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "药明巨诺第2款CAR-T获批临床；康方生物AK120获FDA批准临试",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-28",
            "original_text": "2万亿茅台时隔6年再涨停，白酒大涨8%！机构、外资却吵翻了",
            "features": {
                "keywords": [
                    "茅台",
                    "涨停",
                    "白酒",
                    "机构",
                    "外资"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2万亿茅台时隔6年再涨停，白酒大涨8%！机构、外资却吵翻了",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]